Concepedia

Martin Ryser

MR

Statistics

Publications

19

Citations

3.6K

H-Index

16

Active since

2004

Affiliations

University Hospital Carl Gustav Carus(Current)

National Institute of Allergy and Infectious Diseases

Technische Universität Dresden

Janssen (Belgium)

GlaxoSmithKline (Belgium)

Martin Ryser is an author at University Hospital Carl Gustav Carus specializing in cell biology, life sciences, and vaccinology.

Publications per year

2004–2022

19

Publications

19

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Jerald Sadoff, Glenda Gray, An Vandebosch et al. · New England Journal of Medicine · 2021 · 2.6K citations · Full text

, , +17

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

Jerald Sadoff, Glenda Gray, An Vandebosch et al. · New England Journal of Medicine · 2022 · 250 citations · Full text

, , +12

CXCR4‐Transgene Expression Significantly Improves Marrow Engraftment of Cultured Hematopoietic Stem Cells

Sebastian Brenner, Narda Whiting‐Theobald, Toshinao Kawai et al. · Stem Cells · 2004 · 119 citations · Full text

, , +17

Notch signaling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells

Fernando Ugarte, Martin Ryser, Sebastian Thieme et al. · Experimental Hematology · 2009 · 114 citations

, , +12

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff et al. · The Lancet Infectious Diseases · 2022 · 88 citations · Full text

, , +14

1–5 of 19